+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Ipsen Group - logo

Ipsen is a global specialty-driven pharmaceutical group committed to discovering new solutions for targeted debilitating diseases. The company offers drugs in urology – oncology, endocrinology, neurology, gastroenterology, cognitive disorders, rheumatology, and cardiovascular areas. Its products include Decapeptyl, Hexvix, Somatuline, NutropinAq and Dysport. The company was founded in 1929 and is headquartered in Boulogne-Billancourt, France. Ipsen S.A. is a subsidiary of Mayroy S.A.

Synthetic Hormones Market - A Global and Regional Analysis: Focus on Product Type, Route of Administration, Application, End User, and Region - Analysis and Forecast, 2023-2033 - Product Thumbnail Image

Synthetic Hormones Market - A Global and Regional Analysis: Focus on Product Type, Route of Administration, Application, End User, and Region - Analysis and Forecast, 2023-2033

  • Report
  • February 2024
  • 137 Pages
  • Global
From
Combination Product Services Market by Type of Device Service Focus Area, Company Size, and Key Geographical Regions: Industry Trends and Global Forecasts, 2022-2035 - Product Thumbnail Image

Combination Product Services Market by Type of Device Service Focus Area, Company Size, and Key Geographical Regions: Industry Trends and Global Forecasts, 2022-2035

  • Report
  • August 2022
  • 212 Pages
  • Global
From
The Corporate Reputation of Pharma in 2021 - the Patient Perspective - Rare Disease Edition - The Views of 303 Rare-Disease Patient Groups - Product Thumbnail Image

The Corporate Reputation of Pharma in 2021 - the Patient Perspective - Rare Disease Edition - The Views of 303 Rare-Disease Patient Groups

  • Report
  • October 2022
  • 58 Pages
  • Global
US Orphan Drugs Market, Drugs Sales, Price, Dosage & Clinical Trials Insight 2028 - Product Thumbnail Image

US Orphan Drugs Market, Drugs Sales, Price, Dosage & Clinical Trials Insight 2028

  • Report
  • July 2023
  • 3600 Pages
  • United States
From
Rare Endocrine Disease Treatment - Global Strategic Business Report - Product Thumbnail Image

Rare Endocrine Disease Treatment - Global Strategic Business Report

  • Report
  • July 2025
  • 194 Pages
  • Global
From
Addison's Disease Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Addison's Disease Therapeutics - Global Strategic Business Report

  • Report
  • July 2025
  • 278 Pages
  • Global
From
Endocrinology Drugs - Global Strategic Business Report - Product Thumbnail Image

Endocrinology Drugs - Global Strategic Business Report

  • Report
  • July 2025
  • 288 Pages
  • Global
From
Cabometyx (cabozantinib; Exelixis/Ipsen/Takeda) Drug Overview 2019 - Product Thumbnail Image

Cabometyx (cabozantinib; Exelixis/Ipsen/Takeda) Drug Overview 2019

  • Report
  • September 2019
  • 29 Pages
  • Global
Acromegaly Treatment Market Size, Share & Trends Analysis Report By Drug Class (Somatostatin Analogs, GHRA, Dopamine Agonists), By Distribution Channel (Hospitals & Clinics), By Region, And Segment Forecasts, 2025 - 2030 - Product Thumbnail Image

Acromegaly Treatment Market Size, Share & Trends Analysis Report By Drug Class (Somatostatin Analogs, GHRA, Dopamine Agonists), By Distribution Channel (Hospitals & Clinics), By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • January 2025
  • 100 Pages
  • Global
From
Acromegaly Treatment - Global Strategic Business Report - Product Thumbnail Image

Acromegaly Treatment - Global Strategic Business Report

  • Report
  • July 2025
  • 297 Pages
  • Global
From
Growth Hormone Deficiency - Global Strategic Business Report - Product Thumbnail Image

Growth Hormone Deficiency - Global Strategic Business Report

  • Report
  • July 2025
  • 475 Pages
  • Global
From
Bromhidrosis Disease Treatment - Global Strategic Business Report - Product Thumbnail Image

Bromhidrosis Disease Treatment - Global Strategic Business Report

  • Report
  • July 2025
  • 250 Pages
  • Global
From
Brain Metastasis From Breast Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Brain Metastasis From Breast Cancer - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 50 Pages
  • Global
From
Cervical Dystonia Treatment - Global Strategic Business Report - Product Thumbnail Image

Cervical Dystonia Treatment - Global Strategic Business Report

  • Report
  • July 2025
  • 282 Pages
  • Global
From
Dystonia Drugs - Global Strategic Business Report - Product Thumbnail Image

Dystonia Drugs - Global Strategic Business Report

  • Report
  • July 2025
  • 369 Pages
  • Global
From
Pharmaceutical Drugs Market Report 2025 - Product Thumbnail Image

Pharmaceutical Drugs Market Report 2025

  • Report
  • March 2025
  • 400 Pages
  • Global
From
Skeletal Dysplasia Market - Product Thumbnail Image

Skeletal Dysplasia Market

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Neuroendocrine Tumor Treatment - Global Strategic Business Report - Product Thumbnail Image

Neuroendocrine Tumor Treatment - Global Strategic Business Report

  • Report
  • July 2025
  • 383 Pages
  • Global
From
Angiosarcoma Treatment - Global Strategic Business Report - Product Thumbnail Image

Angiosarcoma Treatment - Global Strategic Business Report

  • Report
  • July 2025
  • 390 Pages
  • Global
From
Prostate Cancer Treatment Market Report by Drug Type, Distribution Channel, and Region 2025-2033 - Product Thumbnail Image

Prostate Cancer Treatment Market Report by Drug Type, Distribution Channel, and Region 2025-2033

  • Report
  • April 2025
  • 137 Pages
  • Global
From
Loading Indicator